Patents-Review.com
🔗 Permalink
Assignee profile:

Tosk, Inc.

City:

Mountain View, California

Country:

United States

Published Applications:

13

Last publication date:

2024-08-22

Patent Grants:

13

Last grant date:

2025-12-02

Top Inventors for applications by Tosk, Inc.

These are the the leading inventors for applications assigned to Tosk, Inc.:

Recent patent applications by Tosk, Inc.

Tosk, Inc. based in Mountain View, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-08-22 ✅ Patent 12,486,255 granted on 2025-12-02
US20240279206A1
Chemistry; metallurgy

Modulators of RAS GTPase

 #2 | 2022-07-21 ✅ Patent 12,528,796 granted on 2026-01-20
US20220227740A1
Chemistry; metallurgy

Modulators of RAS GTPase

 #3 | 2022-04-14 ✅ Patent 12,180,220 granted on 2024-12-31
US20220112205A1
Chemistry; metallurgy

Heteroaryl modulators of RAS GTPase

 #4 | 2022-01-13 ✅ Patent 12,194,043 granted on 2025-01-14
US20220008422A1
Human necessities

Uridine phosphorylase inhibitors to treat or prevent pulmonary disease

 #5 | 2021-08-26 ✅ Patent 11,945,803 granted on 2024-04-02
US20210261532A1
Chemistry; metallurgy

Modulators of RAS GTPase

 #6 | 2021-08-05 ✅ Patent 12,109,222 granted on 2024-10-08
US20210236530A1
Human necessities

Methods and compositions for treating mucositis

 #7 | 2021-07-29 ✅ Patent 12,419,893 granted on 2025-09-23
US20210228584A1
Human necessities

Methods and Compositions for Maximizing the Prevention and/or Reduction of Various Maladies and Drug Side-Effects Using Uridine

 #8 | 2021-07-29 ✅ Patent 12,508,265 granted on 2025-12-30
US20210228583A1
Human necessities

Methods and Compositions for Reducing Radiation Induced Toxicity

 #9 | 2020-12-24 ✅ Patent 11,446,303 granted on 2022-09-20
US20200397790A1
Human necessities

Uridine phosphorylase (UPase) inhibitors for treatment of liver conditions

 #10 | 2020-07-30 ✅ Patent 11,390,626 granted on 2022-07-19
US20200239479A1
Chemistry; metallurgy

Pyrazolopyrimidine modulators of RAS GTPase

 #11 | 2016-09-01 ✅ Patent 10,660,318 granted on 2020-05-26
US20160249593A1
Human necessities

Non-mammalian RAS transgenic animal model

 #12 | 2015-09-17 ✅ Patent 9,468,613 granted on 2016-10-18
US20150258046A1
Human necessities

Doxorubicin adjuvants to reduce toxicity and methods for using the same

 #13 | 2015-03-12 ✅ Patent 9,382,287 granted on 2016-07-05
US20150072945A1
Chemistry; metallurgy

Methotrexate adjuvants to reduce toxicity and methods for using the same

Also check out Tosk, Inc.'s (Mountain View, United States) applicant profile with 16 patent applications submitted.

AssigneeID:

382834 ⎘